WG on Immunodeficiencies

Articles of great interest:

Clinical picture and treatment of 2212 patients with common variable
Gathmann B, Mahlaoui N; CEREDIH, Gérard L, Oksenhendler E, Warnatz K,
Schulze I, Kindle G, Kuijpers TW; Dutch WID, van Beem RT, Guzman D, Workman
S, Soler-Palacín P, De Gracia J, Witte T, Schmidt RE, Litzman J, Hlavackova
E, Thon V, Borte M, Borte S, Kumararatne D, Feighery C, Longhurst H,
Helbert M, Szaflarska A, Sediva A, Belohradsky BH, Jones A, Baumann U,
Meyts I, Kutukculer N, Wågström P, Galal NM, Roesler J, Farmaki E,
Zinovieva N, Ciznar P, Papadopoulou-Alataki E, Bienemann K, Velbri S,
Panahloo Z, Grimbacher B; European Society for Immunodeficiencies Registry
Working Party.
J Allergy Clin Immunol. 2014 Jul;134(1):116-26.

A phenotypic approach for IUIS PID classification and diagnosis: guidelines
for clinicians at the bedside.
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles
C, Etzioni A, Fischer A, Franco JL, Geha RS, Hammarström L, Nonoyama S,
Ochs HD, Roifman CM, Seger R, Tang ML, Puck JM, Chapel H, Notarangelo LD,
Casanova JL.
J Clin Immunol. 2013 Aug;33(6):1078-87.

Primary immunodeficiency diseases: an update on the classification from the
international union of immunological societies expert committee forprimary
Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME,
Cunningham-Rundles C, Etzioni A, Franco JL, Gaspar HB, Holland SM, Klein C,
Nonoyama S, Ochs HD, Oksenhendler E, Picard C, Puck JM, Sullivan K, Tang
Front Immunol. 2014 Apr 22;5:162.

Hyper-IgE syndromes: reviewing PGM3 deficiency.
Yang L, Fliegauf M, Grimbacher B.
Curr Opin Pediatr. 2014 Dec;26(6):697-703.

Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based
sensitization pattern.
Boos AC, Hagl B, Schlesinger A, Halm BE, Ballenberger N, Pinarci M, Heinz
V, Kreilinger D, Spielberger BD, Schimke-Marques LF, Sawalle-Belohradsky J,
Belohradsky BH, Przybilla B, Schaub B, Wollenberg A, Renner ED.
Allergy. 2014 Jul;69(7):943-53

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair
immunity and increase serum IgE levels.
Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T,
Unal E, Ozdemir MA, Jouhadi Z, Khadir K, Ben-Khemis L, Ben-Ali M,
Ben-Mustapha I, Borchani L, Pfeifer D, Jakob T, Khemiri M, Asplund AC,
Gustafsson MO, Lundin KE, Falk-Sörqvist E, Moens LN, Gungor HE, Engelhardt
KR, Dziadzio M, Stauss H, Fleckenstein B, Meier R, Prayitno K, Maul-Pavicic
A, Schaffer S, Rakhmanov M, Henneke P, Kraus H, Eibel H, Kölsch U, Nadifi
S, Nilsson M, Bejaoui M, Schäffer AA, Smith CI, Dell A, Barbouche MR,
Grimbacher B.
J Allergy Clin Immunol. 2014 May;133(5):1410-9

An update on the hyper-IgE syndromes.
Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B.
Arthritis Res Ther. 2012 Nov 30;14(6):228

Primary immune deficiencies with aberrant IgE production.
Ozcan E, Notarangelo LD, Geha RS.
J Allergy Clin Immunol. 2008 Dec;122(6):1054-62
Last updated 12 October 2018
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback